A start-up biotechnology company focused on combining stem cells and immunotherapy to eliminate cancer, has engaged with SeerPharma to help develop a Quality Management System. The company’s revolutionary technology is looking to enhance a patient’s own immune system to tackle cancer.
SeerPharma is assisting a number of start-up biotech companies with implementing a basic Quality Assurance Plan (QAP) – a building block of a fully-fledged Quality Management System. The QAP can be put in place to grow as companies mature.
A number of firms have requested our expertise to provide technical and compliance audits of contract manufacturers that they currently use in Europe and Asia.
Cynata Therapeutics Limited is an Australian stem cell and regenerative medicine company that is developing a therapeutic stem cell platform technology, Cymerus™.
Copyright © SeerPharma
